Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Gastric Cancer

Free Subscription Articles published in J Gastroenterol Hepatol Retrieve available abstracts of 72 articles: HTML format

Single Articles

April 2024
1. ASONUMA S, Hatta W, Koike T, Okata H, et al
   Risk stratification of synchronous gastric cancers including alcohol-related genetic polymorphisms.
   J Gastroenterol Hepatol. 2024 Apr 16. doi: 10.1111/jgh.16570.
   PubMed     Abstract available
   
   
   
2. ZHAN ZQ, Chen YZ, Huang ZM, Luo YH, et al
   Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study.
   J Gastroenterol Hepatol. 2024;39:630-641.
   PubMed     Abstract available
   
   
   
3. WANG Z, He D, Yang JL
   Gastrointestinal: Chronic anemia caused by diffuse lesions of the stomach.
   J Gastroenterol Hepatol. 2024;39:615-616.
   PubMed    
   
   
   March 2024
4. GU L, Wang X, Ouyang M, Li F, et al
   Facilitating endoscopic full-thickness resection for gastric submucosal tumors with a novel snare traction method (with video).
   J Gastroenterol Hepatol. 2024;39:535-543.
   PubMed     Abstract available
   
   
   November 2023
5. DONG X, Chen X, Zhao Y, Wu Q, et al
   CircTMEM87A promotes the tumorigenesis of gastric cancer by regulating the miR-1276/SLC7A11 axis.
   J Gastroenterol Hepatol. 2023 Nov 30. doi: 10.1111/jgh.16402.
   PubMed     Abstract available
   
   
   
6. TANAKA K, Baba Y
   Gastrointestinal: Diminutive Epstein-Barr virus-associated gastric carcinoma.
   J Gastroenterol Hepatol. 2023 Nov 16. doi: 10.1111/jgh.16410.
   PubMed    
   
   
   October 2023
7. MATSUEDA K, Uedo N, Kitamura M, Shichijo S, et al
   Endoscopic features of gastric neuroendocrine carcinoma.
   J Gastroenterol Hepatol. 2023;38:1808-1817.
   PubMed     Abstract available
   
   
   
8. JUNG YS, Tran MTX, Park B, Moon CM, et al
   Mutual association between family history of gastric and colorectal cancer and risk of gastric and colorectal cancer.
   J Gastroenterol Hepatol. 2023;38:1787-1793.
   PubMed     Abstract available
   
   
   September 2023
9. QUEK SXZ, Lee JWJ, Feng Z, Soh MM, et al
   Comparing artificial intelligence to humans for endoscopic diagnosis of gastric neoplasia: An external validation study.
   J Gastroenterol Hepatol. 2023;38:1587-1591.
   PubMed     Abstract available
   
   
   August 2023
10. ZHANG P, Xu T, Wang J, Li Y, et al
    Comparison of different risk stratifications for gastric cancer and establishing a simplified risk-scoring model based on the Kyoto classification.
    J Gastroenterol Hepatol. 2023 Aug 24. doi: 10.1111/jgh.16324.
    PubMed     Abstract available
    
    
    June 2023
11. KAWASAKI K, Torisu T, Esaki M, Eizuka M, et al
    Continuous use of antithrombotic medications during peri-endoscopic submucosal dissection period for colorectal lesions: A propensity score matched study.
    J Gastroenterol Hepatol. 2023;38:955-961.
    PubMed     Abstract available
    
    
    
12. LIU J, Xiang Y, Tang D, Xu G, et al
    Gastrointestinal: A case of type 1 gastric neuroendocrine tumor with multiple endocrine neoplasia type 1.
    J Gastroenterol Hepatol. 2023;38:842.
    PubMed    
    
    
    May 2023
13. TANAKA T, Miwa K, Shimotsuura Y, Nagasu S, et al
    High intramuscular adipose tissue content was a favorable prognostic factor in patients with advanced gastric cancer treated with nivolumab monotherapy.
    J Gastroenterol Hepatol. 2023 May 24. doi: 10.1111/jgh.16239.
    PubMed     Abstract available
    
    
    
14. HIGASHINO M, Ono S, Matsumoto S, Kubo M, et al
    Improvement of detection sensitivity of upper gastrointestinal epithelial neoplasia in linked color imaging based on data of eye tracking.
    J Gastroenterol Hepatol. 2023;38:710-715.
    PubMed     Abstract available
    
    
    April 2023
15. CHEN N, Hu Y, Huang RZ, Chen DL, et al
    Circular RNA circTNIK promotes tumor progression and metastasis in gastric cancer by regulating ZEB2.
    J Gastroenterol Hepatol. 2023 Apr 20. doi: 10.1111/jgh.16189.
    PubMed     Abstract available
    
    
    March 2023
16. NIE X, Zhao C, Zhang Y, Huang W, et al
    Nucleolar protein TCOF1 maintains gastric cancer cell proliferation by regulating R-loop associated DNA replication stress.
    J Gastroenterol Hepatol. 2023 Mar 20. doi: 10.1111/jgh.16181.
    PubMed     Abstract available
    
    
    
17. MATSUURA N, Kato M, Irino T, Hirata K, et al
    Gastrointestinal: Ten-millimeter advanced duodenal cancer with a gastric phenotype.
    J Gastroenterol Hepatol. 2023;38:347.
    PubMed    
    
    
    February 2023
18. LIN R, Qian Y, Zhang J, Xia D, et al
    Genome-wide DNA methylation profiling of gastric cardia cancer.
    J Gastroenterol Hepatol. 2023;38:290-300.
    PubMed     Abstract available
    
    
    December 2022
19. AFIFY AY
    Incidence trends of gastric cancer among adolescents and young adults.
    J Gastroenterol Hepatol. 2022 Dec 28. doi: 10.1111/jgh.16095.
    PubMed    
    
    
    November 2022
20. WEN J, Shen H
    Trend of gastric cancer incidence and death rate in adolescents and young adults: a retrospective cohort study based on the Surveillance, Epidemiology, and End Results (SEER) database.
    J Gastroenterol Hepatol. 2022 Nov 20. doi: 10.1111/jgh.16064.
    PubMed     Abstract available
    
    
    
21. MADHU D, Krishnamurthy V, Natarajan T, Lakhtakia S, et al
    Need for improvement in the evaluation of pre-malignant upper gastro-intestinal lesions in India: Results of a nationwide survey.
    J Gastroenterol Hepatol. 2022;37:2113-2119.
    PubMed     Abstract available
    
    
    October 2022
22. KANEMITSU T, Uedo N, Ono T, Nimura S, et al
    Magnifying endoscopy with narrow-band imaging for diagnosis of subtype of gastric intestinal metaplasia.
    J Gastroenterol Hepatol. 2022 Oct 21. doi: 10.1111/jgh.16034.
    PubMed     Abstract available
    
    
    
23. IM S, Cho YK, Kang D, Shin GY, et al
    Combined High NEDD9 Expression and E-cadherin Loss Correlate with Poor Clinical Outcome in Gastric Cancer.
    J Gastroenterol Hepatol. 2022 Oct 6. doi: 10.1111/jgh.16022.
    PubMed     Abstract available
    
    
    
24. DOHI O, Ono S, Kawada K, Kitamura S, et al
    Linked color imaging provides enhanced visibility with a high color difference in upper gastrointestinal neoplasms.
    J Gastroenterol Hepatol. 2022 Oct 3. doi: 10.1111/jgh.16018.
    PubMed     Abstract available
    
    
    
25. SAWADA H, Czech T, Silangcruz K, Kozai L, et al
    Clinicopathological characteristics of gastric IgG4-related disease: Systematic scoping review.
    J Gastroenterol Hepatol. 2022;37:1865-1872.
    PubMed     Abstract available
    
    
    
26. FUNASAKA K, Miyahara R, Horiguchi N, Omori T, et al
    Novel image enhancement technology that helps find bleeding points during endoscopic submucosal dissection of gastric neoplasms.
    J Gastroenterol Hepatol. 2022;37:1955-1962.
    PubMed     Abstract available
    
    
    August 2022
27. WONG SJ, Wang HP, Shun CT, Chen CC, et al
    Tissue diagnosis necessary for small endoscopic ultrasound-suspected gastric gastrointestinal stromal tumors 2 cm or less in size: A prospective study focusing on the endoscopic incisional biopsy.
    J Gastroenterol Hepatol. 2022;37:1588-1595.
    PubMed     Abstract available
    
    
    July 2022
28. LIU YB, Liu XY, Fang Y, Chen TY, et al
    Comparison of safety and short-term outcomes between endoscopic and laparoscopic resections of gastric gastrointestinal stromal tumors with a diameter of 2-5 cm.
    J Gastroenterol Hepatol. 2022;37:1333-1341.
    PubMed     Abstract available
    
    
    June 2022
29. ZHENG B, Artin MG, Chung H, Chen B, et al
    Immunogenetics of gastrointestinal cancers: A systematic review and retrospective survey of inborn errors of immunity in humans.
    J Gastroenterol Hepatol. 2022;37:973-982.
    PubMed     Abstract available
    
    
    May 2022
30. TANAKA H, Kamata K, Ishihara R, Handa H, et al
    Value of artificial intelligence with novel tumor tracking technology in the diagnosis of gastric submucosal tumors by contrast-enhanced harmonic endoscopic ultrasonography.
    J Gastroenterol Hepatol. 2022;37:841-846.
    PubMed     Abstract available
    
    
    March 2022
31. KIM SH, Hong SJ
    A prospective randomized controlled trial of the safety and efficacy of carbon dioxide insufflation compared with room air insufflation during gastric endoscopic submucosal dissection.
    J Gastroenterol Hepatol. 2022;37:558-567.
    PubMed     Abstract available
    
    
    February 2022
32. HORIUCHI Y, Takizawa K, Yoshio T, Mizusawa J, et al
    Pretreatment risk factors for endoscopic noncurative resection of gastric cancers with undifferentiated-type components.
    J Gastroenterol Hepatol. 2022 Feb 15. doi: 10.1111/jgh.15798.
    PubMed     Abstract available
    
    
    
33. HAYASHI Y, Hatta W, Tsuji Y, Yoshio T, et al
    The degree of mucosal atrophy is associated with post-endoscopic submucosal dissection bleeding in early gastric cancer.
    J Gastroenterol Hepatol. 2022 Feb 7. doi: 10.1111/jgh.15793.
    PubMed     Abstract available
    
    
    January 2022
34. SHINMURA K, Yamamoto Y, Inaba A, Okumura K, et al
    The safety and feasibility of endoscopic submucosal dissection using a flexible three-dimensional endoscope for early gastric cancer and superficial esophageal cancer: A prospective observational study.
    J Gastroenterol Hepatol. 2022 Jan 25. doi: 10.1111/jgh.15784.
    PubMed     Abstract available
    
    
    
35. ZHANG Y, Bai J, Cheng R, Zhang D, et al
    TAZ promotes vasculogenic mimicry in gastric cancer through the upregulation of TEAD4.
    J Gastroenterol Hepatol. 2022 Jan 21. doi: 10.1111/jgh.15779.
    PubMed     Abstract available
    
    
    
36. SU W, Wang M, Zhang D, Zhu Y, et al
    Predictors of the difficulty for endoscopic resection of gastric gastrointestinal stromal tumor and follow-up data.
    J Gastroenterol Hepatol. 2022;37:48-55.
    PubMed     Abstract available
    
    
    
37. GUO L, Ma H, Kong Y, Leng G, et al
    Long non-coding RNA TNK2 AS1/microRNA-125a-5p axis promotes tumor growth and modulated phosphatidylinositol 3 kinase/AKT pathway.
    J Gastroenterol Hepatol. 2022;37:124-133.
    PubMed     Abstract available
    
    
    December 2021
38. CHENG X, Sun X, Wang Q
    Gastrointestinal: Massive gastric juvenile polyposis.
    J Gastroenterol Hepatol. 2021;36:3258.
    PubMed    
    
    
    November 2021
39. LI F, Zhu H, Tao K, Xia Y, et al
    Mucosal microbial microenvironment in early gastric neoplasia and non-neoplastic gastric disease.
    J Gastroenterol Hepatol. 2021;36:3092-3101.
    PubMed     Abstract available
    
    
    
40. KIMURA H, Yabuuchi Y, Notsu A, Yamamoto Y, et al
    Features of post-endoscopic submucosal dissection electrocoagulation syndrome for early gastric neoplasm.
    J Gastroenterol Hepatol. 2021;36:3164-3169.
    PubMed     Abstract available
    
    
    October 2021
41. HAMADA K, Kawahara Y, Tanimoto T, Ohto A, et al
    Application of convolutional neural networks for evaluating the depth of invasion of early gastric cancer based on endoscopic images.
    J Gastroenterol Hepatol. 2021 Oct 28. doi: 10.1111/jgh.15725.
    PubMed     Abstract available
    
    
    
42. LIU Y, Lin D, Li L, Chen Y, et al
    Using machine-learning algorithms to identify patients at high risk of upper gastrointestinal lesions for endoscopy.
    J Gastroenterol Hepatol. 2021;36:2735-2744.
    PubMed     Abstract available
    
    
    September 2021
43. LIU J, Wang Y, Liu Z, Lv L, et al
    Submucosal tunneling endoscopic resection treatment of multiple gastrointestinal submucosal tumors.
    J Gastroenterol Hepatol. 2021;36:2575-2580.
    PubMed     Abstract available
    
    
    
44. WU CCH, Namasivayam V, Li JW, Khor CJ, et al
    A prospective randomized tandem gastroscopy pilot study of linked color imaging versus white light imaging for detection of upper gastrointestinal lesions.
    J Gastroenterol Hepatol. 2021;36:2562-2567.
    PubMed     Abstract available
    
    
    
45. LEE JM, Yoo IK, Hong SP, Cho JY, et al
    A modified endoscopic full thickness resection for gastric subepithelial tumors from muscularis propria layer: Novel method.
    J Gastroenterol Hepatol. 2021;36:2558-2561.
    PubMed     Abstract available
    
    
    August 2021
46. DESAI M, Boregowda U, Srinivasan S, Kohli DR, et al
    Narrow band imaging for detection of gastric intestinal metaplasia and dysplasia: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2021;36:2038-2046.
    PubMed     Abstract available
    
    
    
47. CHOE YH, Jung DH, Park JC, Kim HY, et al
    Prediction model for bleeding after endoscopic submucosal dissection of gastric neoplasms from a high-volume center.
    J Gastroenterol Hepatol. 2021;36:2217-2223.
    PubMed     Abstract available
    
    
    July 2021
48. CHO JH, Jin SY, Park S
    Scoring model for discriminating gastric cancer risk in patients with negative serum pepsinogen and anti-Helicobacter pylori antibody results.
    J Gastroenterol Hepatol. 2021 Jul 19. doi: 10.1111/jgh.15630.
    PubMed     Abstract available
    
    
    June 2021
49. GAO X, Guo R, Li Y, Kang G, et al
    Upregulated aminoacyl-tRNA biosynthesis contributes to metabolic dysregulation in gastric cancer.
    J Gastroenterol Hepatol. 2021 Jun 22. doi: 10.1111/jgh.15592.
    PubMed     Abstract available
    
    
    
50. HUSSEIN M, Alzoubaidi D, O'Donnell M, de la Serna A, et al
    Hemostatic powder TC-325 treatment of malignancy-related upper gastrointestinal bleeds: International registry outcomes.
    J Gastroenterol Hepatol. 2021 Jun 15. doi: 10.1111/jgh.15579.
    PubMed     Abstract available
    
    
    
51. YAN Z, Yan Q, Song Y, Wang L, et al
    TMSB10 can serve as a potential prognosis prediction biomarker and promotes the invasion and angiogenesis of gastric cancer.
    J Gastroenterol Hepatol. 2021 Jun 11. doi: 10.1111/jgh.15576.
    PubMed     Abstract available
    
    
    
52. ZIMMER V, Heinrich C, Mues EP
    Gastrointestinal: Franseen-tip transmural fine-needle biopsy for localized gastric linitis plastica.
    J Gastroenterol Hepatol. 2021;36:1389.
    PubMed    
    
    
    May 2021
53. CHOI IY, Choi YJ, Shin DW, Han KD, et al
    Association between obesity and the risk of gastric cancer in pre and postmenopausal women: A nationwide cohort study.
    J Gastroenterol Hepatol. 2021 May 25. doi: 10.1111/jgh.15558.
    PubMed     Abstract available
    
    
    
54. YANG LS, Taylor ACF, Thompson AJ, Desmond PV, et al
    Quantifying early gastric cancer in Australia: What is the opportunity for gastric endoscopic submucosal dissection?
    J Gastroenterol Hepatol. 2021 May 22. doi: 10.1111/jgh.15552.
    PubMed     Abstract available
    
    
    
55. SHIROMA S, Hatta W, Tsuji Y, Yoshio T, et al
    Timing of bleeding and thromboembolism associated with endoscopic submucosal dissection for gastric cancer in Japan.
    J Gastroenterol Hepatol. 2021 May 7. doi: 10.1111/jgh.15536.
    PubMed     Abstract available
    
    
    March 2021
56. CHUA WJ, Karasinghe K, Tan D
    Gastrointestinal: Carney's triad complicated by a metastasized and bleeding gastrointestinal stromal tumor.
    J Gastroenterol Hepatol. 2021;36:587.
    PubMed    
    
    
    February 2021
57. AKADA J, Tshibangu-Kabamba E, Tuan VP, Kurogi S, et al
    Serum Helicobacter pylori antibody reactivity in seven Asian countries using an automated latex aggregation turbidity assay.
    J Gastroenterol Hepatol. 2021 Feb 20. doi: 10.1111/jgh.15467.
    PubMed     Abstract available
    
    
    
58. ZHANG H, Li X, Wu J, Zhang J, et al
    A qualitative transcriptional signature of recurrence risk for stageII-III gastric cancer patients after surgical resection.
    J Gastroenterol Hepatol. 2021 Feb 10. doi: 10.1111/jgh.15439.
    PubMed     Abstract available
    
    
    
59. UEYAMA H, Yatagai N, Ikeda A, Akazawa Y, et al
    Dynamic diagnosis of early gastric cancer with microvascular blood flow rate using magnifying endoscopy (with video): a pilot study.
    J Gastroenterol Hepatol. 2021 Feb 3. doi: 10.1111/jgh.15425.
    PubMed     Abstract available
    
    
    January 2021
60. KATO M, Hayashi Y, Nishida T, Oshita M, et al
    Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild-to-moderate atrophic gastritis.
    J Gastroenterol Hepatol. 2021 Jan 5. doi: 10.1111/jgh.15396.
    PubMed     Abstract available
    
    
    
61. YU H, Singh R, Shin SH, Ho KY, et al
    Artificial intelligence in upper GI endoscopy - current status, challenges and future promise.
    J Gastroenterol Hepatol. 2021;36:20-24.
    PubMed     Abstract available
    
    
    
62. XIAO S, Fan Y, Yin Z, Zhou L, et al
    Endoscopic grading of gastric atrophy on risk assessment of gastric neoplasia: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2021;36:55-63.
    PubMed     Abstract available
    
    
    
63. IWAGAMI H, Ishihara R, Aoyama K, Fukuda H, et al
    Artificial intelligence for the detection of esophageal and esophagogastric junctional adenocarcinoma.
    J Gastroenterol Hepatol. 2021;36:131-136.
    PubMed     Abstract available
    
    
    December 2020
64. HU Y, Zhang Y, Ding M, Xu R, et al
    LncRNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway.
    J Gastroenterol Hepatol. 2020 Dec 8. doi: 10.1111/jgh.15362.
    PubMed     Abstract available
    
    
    October 2020
65. YAMAOKA M, Imaeda H, Miyaguchi K, Ashitani K, et al
    Detection of early stage gastric cancers in screening laser endoscopy using linked color imaging for patients with atrophic gastritis.
    J Gastroenterol Hepatol. 2020 Oct 30. doi: 10.1111/jgh.15312.
    PubMed     Abstract available
    
    
    
66. JOEL LWL, Mark KJW, Hao LX, Zhi LT, et al
    Opportunistic upper endoscopy during colonoscopy as a screening strategy for countries with intermediate gastric cancer risk.
    J Gastroenterol Hepatol. 2020 Oct 10. doi: 10.1111/jgh.15290.
    PubMed     Abstract available
    
    
    
67. ASHINA S, Sakai A, Masuda A, Tsujimae M, et al
    Gastrointestinal: Gastric outlet obstruction caused by a hamartomatous inverted polyp and an ectopic pancreas.
    J Gastroenterol Hepatol. 2020;35:1667.
    PubMed    
    
    
    September 2020
68. ZHU M, Cao B, Li X, Li P, et al
    Risk factors and a predictive nomogram for lymph node metastasis of superficial esophagogastric junction cancer.
    J Gastroenterol Hepatol. 2020;35:1524-1531.
    PubMed     Abstract available
    
    
    August 2020
69. CHENG J, Xu X, Zhuang Q, Luo S, et al
    Endoscopic acanthosis nigricans appearance: A novel specific marker for diagnosis of low-grade intraepithelial neoplasia.
    J Gastroenterol Hepatol. 2020;35:1372-1380.
    PubMed     Abstract available
    
    
    July 2020
70. KONO Y, Kusumoto C, Kiguchi T, Okada H, et al
    Gastrointestinal: Rapid emergence of double-expressor lymphoma after Helicobacter pylori eradication therapy.
    J Gastroenterol Hepatol. 2020 Jul 9. doi: 10.1111/jgh.15162.
    PubMed    
    
    
    February 2020
71. NAM JH, Nam SY, Park BJ, Ryu KH, et al
    Effect of Helicobacter pylori Infection and its Eradication on Gastric Regenerating Atypia in 22,133 Subjects.
    J Gastroenterol Hepatol. 2020 Feb 21. doi: 10.1111/jgh.15016.
    PubMed     Abstract available
    
    
    November 2019
72. NOTSU T, Adachi K, Mishiro T, Ishimura N, et al
    Fundic gland polyp prevalence according to Helicobacter pylori infection status.
    J Gastroenterol Hepatol. 2019 Nov 16. doi: 10.1111/jgh.14934.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.